Last updated: April 10, 2024
Sponsor: Maxima Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Connective Tissue Diseases
Autoimmune Disease
Genitourinary Prolapse
Treatment
Mesh removal
blood tests
mesh allergy test
Clinical Study ID
NCT06363903
2022-MMC-051
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients >18 years of age and written informed consent obtained;
- Suspected ASIA syndrome after elective hernia, pelvic organ prolapse (POP) surgery, orstress urinary incontinence (SUI) repair, defined as three major ASIA criteria (Table 1), of which the exposure to an external stimulus (PP mesh) is one;
- ASIA complaints evolved after the implantation of PP mesh and were not present beforethe surgical repair.
Exclusion
Exclusion Criteria:
- Known auto-immune disorders;
- Known malignancies;
- (Low grade) infections or other inflammatory diseases at time of surgery;
- Cognitively impaired individuals.
Study Design
Total Participants: 50
Treatment Group(s): 3
Primary Treatment: Mesh removal
Phase:
Study Start date:
May 09, 2022
Estimated Completion Date:
May 31, 2025
Study Description
Connect with a study center
Maastricht University Medical Centre
Maastricht, Limburg 6229HX
NetherlandsSite Not Available
Maxima Medical Centre
Veldhoven, Noord-Brabant 5504DB
NetherlandsActive - Recruiting
Amsterdam UMC
Amsterdam, Noord-Holland 1105AZ
NetherlandsSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.